• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Up­dat­ed: FDA clears first CD20xCD3 bis­pe­cif­ic, giv­ing Genen­tech leg up in a crowd­ed lym­phoma R&D field

3 years ago
R&D
Pharma

FDA qui­et­ly turns Keytru­da ac­cel­er­at­ed ap­proval for less-fre­quent dos­ing in­to full ap­proval

3 years ago
Pharma
FDA+

Decades of di­ver­si­ty ini­tia­tives lat­er, cer­tain groups re­main 'con­sis­tent­ly un­der­rep­re­sent­ed' in can­cer tri­als, GAO ...

3 years ago
Pharma

Roche's Actem­ra wins ap­proval for hos­pi­tal­ized Covid pa­tients

3 years ago
Pharma
FDA+

Man­u­fac­tur­ing roundup: As­traZeneca widens part­ner­ship in Abu Dhabi; Mod­er­na fi­nal­izes its part­ner­ship with the UK

3 years ago
Manufacturing

Start­up mak­ing soft­ware for phar­ma man­u­fac­tur­ing in­dus­try nets $12M+ Se­ries A

3 years ago
Financing
Startups

Stifel Fi­nan­cial swal­lows life sci­ences in­vest­ment bank Tor­reya Part­ners

3 years ago
Deals

Lex­i­con Phar­ma­ceu­ti­cals an­nounces mid-stage pain fail, blames dos­ing choice

3 years ago
R&D

Gilead wins ap­proval for long-act­ing HIV in­jec­tion af­ter re­solv­ing vial con­cerns

3 years ago
FDA+

Mor­phoSys CFO Sung Lee ex­its as shares suf­fer in mar­ket melt­down

3 years ago
R&D

Vax­cyte makes deal with Sutro Bio­phar­ma to take over man­u­fac­tur­ing of vac­cine com­po­nent

3 years ago
Deals
Manufacturing

Vista­gen ac­quires Pherin Phar­ma­ceu­ti­cals for 12.4M shares and 'nom­i­nal' cash

3 years ago
Deals

Up­dat­ed: ICER on Alzheimer's: lecanemab should be priced low­er than Aduhelm

3 years ago
Pharma

Berke­ley Lights to ac­quire Iso­Plex­is in $57.8M all-stock deal

3 years ago
Deals

Eli Lil­ly ties up 2022 by ex­pand­ing deal with bat­tered RNA-edit­ing biotech

3 years ago
Deals
R&D

Back again: Mer­ck will­ing to dole out more than $9B for Kelun’s AD­Cs

3 years ago
Deals
China

Rid­ing on pos­i­tive PhI­II NASH da­ta, Madri­gal rais­es $300M for road to FDA

3 years ago
Financing

Alex Hard­ing to chase in­dus­try dreams at CRISPR Ther­a­peu­tics; Scoop: Bio­gen’s head of busi­ness de­vel­op­ment splits ...

3 years ago
Peer Review

Catch­ing up in mul­ti­ple myelo­ma, Pfiz­er taps ORIC for BC­MA com­bo study

3 years ago
R&D

BioSpring in­vests €100M+ in­to new oligonu­cleotide API fa­cil­i­ties in Ger­many

3 years ago
Pharma
Manufacturing

Vir­ginia Rep. Span­berg­er asks FDA, DEA chiefs to re­spond to Adder­all short­ages

3 years ago
Pharma
FDA+

Up­dat­ed: BioN­Tech sends mR­NA Covid-19 vac­cines to Chi­na for 20,000 ex­pats

3 years ago
Coronavirus

New year, new hire: Mod­er­na taps Mer­ck vet­er­an as lat­est com­mer­cial ex­ec

3 years ago
Pharma
Marketing

CBER's Pe­ter Marks says Covid-19 shots to mir­ror flu shots: Man­u­fac­tur­ers will be in­ter­change­able

3 years ago
FDA+
Coronavirus
First page Previous page 398399400401402403404 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.